These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 16765651

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review.
    Gisbert JP, Gomollón F.
    Am J Gastroenterol; 2008 Jul; 103(7):1783-800. PubMed ID: 18557712
    [Abstract] [Full Text] [Related]

  • 4. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study.
    Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH.
    Gastroenterology; 2003 Jan; 124(1):9-17. PubMed ID: 12512024
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of low dose azathioprine/6-mercaptopurine in patients with inflammatory bowel disease.
    Kim DU, Kim YH, Kim BJ, Chang DK, Son HJ, Rhee PL, Kim JJ, Rhee JC.
    Hepatogastroenterology; 2009 Jan; 56(94-95):1395-402. PubMed ID: 19950798
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The association between corticosteroid use and development of fractures among IBD patients in a population-based database.
    Bernstein CN, Blanchard JF, Metge C, Yogendran M.
    Am J Gastroenterol; 2003 Aug; 98(8):1797-801. PubMed ID: 12907335
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.
    Gisbert JP, Luna M, Maté J, González-Guijarro L, Cara C, Pajares JM.
    Hepatogastroenterology; 2006 Aug; 53(69):399-404. PubMed ID: 16795981
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease.
    López-Martín C, Chaparro M, Espinosa L, Bejerano A, Maté J, Gisbert JP.
    Gastroenterol Hepatol; 2011 Aug; 34(6):385-92. PubMed ID: 21616565
    [Abstract] [Full Text] [Related]

  • 13. Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center.
    Banerjee S, Bishop WP.
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):324-30. PubMed ID: 16954954
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of azathioprine and 6-mercaptopurine in Japanese pediatric patients with ulcerative colitis: a survey of the Japanese Society for Pediatric Inflammatory Bowel Disease.
    Tajiri H, Tomomasa T, Yoden A, Konno M, Sasaki M, Maisawa S, Sumazaki R, Shimizu T, Toyoda S, Etani Y, Nakacho M, Ushijima K, Kobayashi A, Japanese Society for Pediatric Inflammatory Bowel Disease.
    Digestion; 2008 Sep; 77(3-4):150-4. PubMed ID: 18577852
    [Abstract] [Full Text] [Related]

  • 15. Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease.
    Ananthakrishnan AN, Attila T, Otterson MF, Lipchik RJ, Massey BT, Komorowski RA, Binion DG.
    J Clin Gastroenterol; 2007 Aug; 41(7):682-8. PubMed ID: 17667053
    [Abstract] [Full Text] [Related]

  • 16. [The frequency and the course of the adverse effects of azathioprine/6-mercaptopurine treatment in patients with inflammatory bowel disease].
    Kim JH, Cheon JH, Kim WH.
    Korean J Gastroenterol; 2008 May; 51(5):291-7. PubMed ID: 18516013
    [Abstract] [Full Text] [Related]

  • 17. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis.
    Bermejo F, Lopez-Sanroman A, Taxonera C, Gisbert JP, Pérez-Calle JL, Vera I, Menchén L, Martín-Arranz MD, Opio V, Carneros JA, Van-Domselaar M, Mendoza JL, Luna M, López P, Calvo M, Algaba A.
    Aliment Pharmacol Ther; 2008 Sep 01; 28(5):623-8. PubMed ID: 18513380
    [Abstract] [Full Text] [Related]

  • 18. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?
    Bernstein CN, Blanchard JF, Metge C, Yogendran M.
    Am J Gastroenterol; 2003 Dec 01; 98(12):2784-8. PubMed ID: 14687833
    [Abstract] [Full Text] [Related]

  • 19. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.
    Su C, Lichtenstein GR.
    Gastroenterol Clin North Am; 2004 Jun 01; 33(2):209-34, viii. PubMed ID: 15177535
    [Abstract] [Full Text] [Related]

  • 20. Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease.
    Korelitz BI, Fuller SR, Warman JI, Goldberg MD.
    Am J Gastroenterol; 1999 Feb 01; 94(2):424-6. PubMed ID: 10022640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.